Company Active LTD

Company profile

Sibelius Ltd

Sibelius Natural Products - Ingredients for Supplements

Sibelius Supports wellness with plant-based ingredients, takes traditionally used ingredients and provides the supporting scientific evidence.

CRN
06949779
Founded
2009
Age
17

Overview

Legal name
SIBELIUS LTD
Region
South East England
Registered address
6-7 CITIBASE, NEW BARCLAY HOUSE
234 BOTLEY ROAD
OXFORD
ENGLAND
OX2 0HP
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

Sibelius Ltd
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

9 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

15 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

01 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

21 Oct
2024

Accounts With Accounts Type Small

Accounts Analysed

AA | Transaction MzQ0MDMxODYwMWFkaXF6a2N4

Published 21 Oct 2024 02:50

18 Sep
2024

Gazette Filings Brought Up To Date

Gazette

DISS40 | Transaction MzQzNjIyODEwMmFkaXF6a2N4 | Paper/PDF filed

Published 19 Sep 2024 06:03

17 Sep
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQzNjIyODAzNWFkaXF6a2N4

Published 17 Sep 2024 15:47

17 Sep
2024

Gazette Notice Compulsory

Gazette

GAZ1 | Transaction MzQzNTA0ODY4MWFkaXF6a2N4 | Paper/PDF filed

Published 13 Sep 2024 11:51

01 Jul
2009

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2021
Funded years
2021
Age at first award
11 years

Projects

2021 Collaborative R&D Lead participant

A method for system-wide identification of target proteins and their ligands from complex extracts of natural products

1 Apr 2021 to 31 Aug 2022

Awarded
£143,740
Total cost £205,343

Ageing populations, increasing rates of lifestyle-related conditions and costs of drug development/healthcare provision represents a global societal challenge. 'Self-care' - "the ability of individuals, families and communities to promote health, prevent disease, maintain health, and to cope with illness and disability with or without the support of a hea...

Product types

Collaborative R&D